AS Orthana® versus Biotène Oralbalance® for patients with dry mouth

Not Applicable

Completed

• Conditions: Dry mouth / xerostomia; Digestive System; Xerostomia

• Registration Number: ISRCTN71177327
• Lead Sponsor: Pennine Acute Hospitals NHS Trust (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-10-16
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. Patients who are referred to the Oral Maxillofacial Surgery Department at North Manchester General Hospital with dry mouth / xerostomia
2. Patients whom clinicians have advised to use an artificial saliva product
3. Patients aged 18 years and over from of either gender
4. Patients must be able to communicate in English

Exclusion Criteria

1. Patients who lack the capacity to consent to participation in the study
2. Patients below 18 years old
3. Patients who are unable communicate in English
4. Patients who are felt to be in the last hours or days of life (i.e. on the Liverpool Pathway for Care of the Dying Patient - LCP)
5. Patients involved in another current research

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Improvement of patient symptoms reflected by VAS<br>2. The Summated Xerostomia Inventory Questionnaire<br><br>At baseline, after 5 days from start of the first product and after 5 days from the start of second product.

Secondary Outcome Measures

Name	Time	Method
Patient preference for one of the two products measured after 5 days from the start of second product